8-K: BiomX Announces 1-for-10 Reverse Stock Split

BiomX Inc. is implementing a 1-for-10 reverse stock split to reduce its outstanding shares and comply with exchange listing requirements.

Summary

• BiomX Inc. announced a 1-for-10 reverse stock split of its common stock, effective September 9, 2026.
• This action was approved by stockholders on August 25, 2026, and will reduce the number of authorized shares from 750,000,000 to 150,000,000.
• The reverse stock split is expected to reduce the number of outstanding shares from approximately 26.7 million to 2.7 million.
• The common stock is expected to trade on a split-adjusted basis on the NYSE American starting September 9, 2026.
• No fractional shares will be issued; shareholders entitled to fractional shares will have their holdings rounded up to the next whole share.
• Adjustments will be made to the exercise prices and number of shares for outstanding warrants, convertible instruments, and equity awards.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative development, as reverse stock splits are often associated with companies struggling to maintain stock price compliance or attract investment.

Positives

• Aims to improve the stock's marketability and potentially meet exchange listing requirements.
• Ensures all stockholders are treated uniformly, with fractional shares rounded up to the next whole share.
• Proportionate adjustments to equity instruments will maintain the intended economic value for holders.

Negatives

• Reverse stock splits are often perceived negatively by the market, potentially signaling underlying business challenges.
• The reduction in authorized shares from 750 million to 150 million significantly dilutes potential future share issuances.

Risks

• The reverse stock split may not achieve its intended effect of increasing the stock price or improving market perception.
• Potential for continued volatility and price decline even after the split.
• Risks associated with the filing and effectiveness of the Certificate of Amendment.
• Processing of corporate actions by NYSE American.
• Other risks detailed in the company's SEC filings, including its Form 10-K for the fiscal year ended December 31, 2025.

Future Outlook

The company expects the reverse stock split to become effective at 12:01 a.m. Eastern Time on September 9, 2026, with common stock trading on a split-adjusted basis on the NYSE American from the market open on that date. The number of authorized shares will be reduced to 150,000,000.

Management Comments

• The Company expects to file a Certificate of Amendment to its Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware giving effect to the Reverse Stock Split (together with the reduction in authorized shares), to become effective at 12:01 a.m., Eastern Time, on September 9, 2026.

Industry Context

StockSavvy.ai notes that reverse stock splits are a common, albeit often controversial, tool used by companies, particularly those in the biotechnology sector, to regain compliance with minimum stock price requirements on major exchanges like the NYSE American. This action is often a precursor to other strategic moves or a response to sustained low stock valuations.

Corporate Governance

Stakeholder Impact

• Shareholders will see their number of shares reduced by a factor of ten, but their percentage ownership interest will remain largely the same, except for minor adjustments due to fractional share treatment.
• Holders of warrants, convertible instruments, and equity awards will experience proportionate adjustments to exercise prices and share counts.

Next Steps

• Filing of a Certificate of Amendment to the Amended and Restated Certificate of Incorporation with the Secretary of State of the State of Delaware.
• The common stock will begin trading on the NYSE American on a split-adjusted basis on September 9, 2026.
• Continental Stock Transfer & Trust Company will act as the exchange agent for the reverse stock split.
• The Company will report the filing and effectiveness of the Certificate of Amendment under Item 5.03 of Form 8-K following the effective time.

Key Dates

Recommendation

The reverse stock split is a procedural move often undertaken by companies facing stock price challenges. While it can improve marketability and compliance, it does not inherently change the company's underlying business performance or prospects. Therefore, a 'hold' recommendation is appropriate pending further developments or fundamental improvements in the company's operations and financial results.

Keywords

Reverse Stock Split, Common Stock, Stockholder Approval, Authorized Shares, NYSE American, Fractional Shares, Warrants, Equity Awards